
1. int j parasitol. 2018 mar;48(3-4):203-209. doi: 10.1016/j.ijpara.2017.10.004.
epub 2018 jan 13.

the shikimate pathway enzyme generates chorismate required the
development plasmodium berghei mammalian host mosquito vector.

choudhary hh(1), srivastava pn(1), singh s(2), kumar ka(3), mishra s(4).

author information: 
(1)division parasitology, csir-central drug research institute, lucknow
226031, india.
(2)csir-indian institute integrative medicine, canal road, jammu 180001,
india.
(3)department animal biology, school life sciences, university of
hyderabad, hyderabad 500046, india.
(4)division parasitology, csir-central drug research institute, lucknow
226031, india. electronic address: satish.mishra@cdri.res.in.

in plasmodium, shikimate pathway potential target malaria
chemotherapy owing absence mammalian host. chorismate, end
product pathway, serves precursor aromatic amino acids,
para-aminobenzoic acid ubiquinone, synthesised chorismate synthase 
(cs). therefore, follows cs locus may refractory genetic
manipulation. utilising conditional mutagenesis system yeast flp/frt, 
demonstrate unexpectedly dispensable role cs plasmodium. studies
reiterate need establish obligate reliance plasmodium metabolic
enzymes genetic approaches selection drug targets.

copyright Â© 2018 australian society parasitology. published elsevier ltd. 
all rights reserved.

doi: 10.1016/j.ijpara.2017.10.004 
pmid: 29338985  [indexed medline]

